Association between asthma control and Interleukin-17F expression levels in adult patients with atopic asthma

Eko E. Surachmanto, Mochammad Hatta, Andi A. Islam, Syarifuddin Wahid


Objectives: To investigate the correlation between Interleukin 17 (IL-17F) and the level of asthma control.

: This is a cross-sectional study of 40 subjects who were diagnosed with atopic asthma. All participants were recruited from the Allergy and Immunology Clinic, Prof. R.D. Kandou General Hospital, Manado, Indonesia, between April 2015 and April 2016. Total serum IL-17F measured by using Enzyme-Linked Immunosorbent Assay methods; and mRNA IL-17F was obtained by using real-time reverse transcriptase polymerase chain reaction. Level of asthma control was quantified by using asthma control test (ACT) scoring system. The correlation between IL-17F, mRNA, and level of asthma control was analyzed by using Pearson’s correlation coefficient (r).

: There is a strong positive correlation between IL-17F serum level and Nathan’s ACT-score (r=0.969) which is statistically significant (p less than 0.001). Analysis of the correlation between mRNA IL-17F serum level and Nathan’s ACT-score revealed a strong positive correlation (r=0.963), which is statistically significant (p less than 0.001).

: These findings suggest that IL-17F plays an important role in asthma control. However, the role played by IL-17F in asthma pathogenesis are still questions to be answered.


Saudi Med J 2018; Vol. 39 (7): 662-667
doi: 10.15537/smj.2018.7.22055

How to cite this article:
Surachmanto EE, Hatta M, Islam AA, Wahid S. Association between asthma control and Interleukin-17F expression levels in adult patients with atopic asthma. Saudi Med J. 2018 Jul;39(7):662-667. doi: 10.15537/smj.2018.7.22055.


IL-17F; Asthma control; Atopic Asthma

Full Text:



Global Initiative for Asthma. Global strategy for asthma management and prevention [Updated 2015]. Available from URL:

Sundaru H, Sukamto. Asma bronkial. In: Sudoyo AW, Setiyohadi B, Alwi I, Simadibrata M, Setiati S. editors. Buku Ajar Ilmu Penyakit Dalam edisi ke 6. Jakarta: Internal Publishing; 2014.

Lazarus S. Emergency Treatment of Asthma. N Eng J Med 2010; 363: 755-764.

Centers for Disease Control and Prevention. Data from the CDC National Asthma Control Program 2012 [Internet]. Atlanta, GA. [cited 2015 Oct 6]. Available from:

Ten Hacken NH, Oosterhoff Y, Kauffman HF, Guevarra L, Satoh T, Tollerud DJ, et al. Elevated serum interferon-γ in atopic asthma correlates with increased airways responsiveness and circadian peak expiratory flow variation. Eur Respir J 1998; 11: 312-316.

Holgate ST. Innate and adaptive immune responses in asthma. Nature Medicine 2012; 18: 673-685.

Ota K, Kawaguchi M, Matsukura S, Kurokawa M, Kokubu F. Potensial Involvement of IL-17F in Asthma. J Immunol Res 2014; 2014: 602846.

Nathan RA, Sorkness CA, Kosinski M, Schatz M, Li JT, et al. Development of the Asthma Control. A survey for assessing asthma control. J Allergy Clin Immunol 2004; 113: 59-65.

Sterk PJ, Lutter R. Asthma phenotyping: TH2-high, TH2 low and beyond. J Allergy Clin Immunol 2014; 133: 395-396.

Woodruff PG, Modrek B, Choy DF, Jia G, Abbas AR, Ellwanger A et al. T-helper type 2-driven inflammation defines major subphenotypes of asthma. Am J Respir Crit Care Med 2009; 180: 388-395.

Hansen G, Berry G, DeKruyff RH, Umetsu DT. Allergen-spesific Th1 cells fail to counterbalance Th2 cell-induced airway hyperactivity but cause severe airway inflammation. J Clin Invest 1999; 103: 175-183.

Kim YM, Kim YS, Jeon SG, Kim YK, Immunopathogenesis of allergic asthma: more than the Th2 hypothesis. Allergy Asthma Immunol Res 2013; 5: 189-196.

Pappu R, Carrozzi VR, Sambandam A. The interleukin-17 cytokine family: critical players in host defence and inflammatory diseases. Immunology 2011; 134: 8-16.

Jin W, Dong C. IL-17 cytokines in immunity and inflammation. Emerging Microbes and Infections 2013; 2: 1-5.

Bazzi MD, Sultan MA, Tassan AI, Alanazi M, Al-Amri A, et al. Interleukin (IL)-17A and IL-17F and Asthma in Saudi Arabia: mRNA transcript level and gene Polymorphisms. African Journal of Biotechnology 2013; 12: 3615-36210.

Chang SH, Dong C. IL-17F: regulation, signaling and function in inflammation. Cytokine 2009; 46: 7-11.

Yang XO, Chang SH, Park H, Nurieva R, Shah B, Acero L et al. Regulation of inflammatory responses by IL-17F. J Exp Med 2008; 205: 1063-1075.

Sorbello V, Ciprandi G, Stefano AD, Massaglia GM, Favata G, Conticello S, et al. Nasal IL-17F is related to bronchial IL-17F/neutrophilia and exacerbations in stable atopic severe asthma. Allergy 2015; 70: 236-240.

Alyasin S, Karimi MH, Amin R, Babaei M, Darougar S. Interleukin-17 gene expression and serum levels in children with severe asthma. Iran J Immunol 2013; 10: 179-187.

Agache I, Ciobanu C, Agache C, Anghel M. Increased serum IL-17 is an independent risk factor for severe asthma. Respiratory Medicine 2010; 104: 1131-1137.

Al-Ramli W, Prefontaine D, Chouiali F, Martin JG, Olivenstein R, Lemiere C, et al. TH17-associated cytokine (IL17-A and IL-17F) in severe asthma. J Allergy Clin Immunol 2009; 123: 1185-1187.

Choy DF, Hart KM, Borthwick LA, Shikotra A, Nagarkar DR, Siddiqui S, et al. TH2 and TH17 inflammatory pathways are reciprocally regulated in asthma. Sci Transl Med 2015; 7: 301ra129.

Oda N, Canelos PB, Essayan DM, Plunkett BA, Myers AC, Huang SK. Interleukin-17F induces pulmonary neutrophilia and amplifies antigen-induced allergic response. Am J Respir Crit Care Med 2005; 171: 12-18.


  • There are currently no refbacks.

Saudi Medical Journal is copyright under the Berne Convention and the International Copyright Convention.  Saudi Medical Journal is an Open Access journal and articles published are distributed under the terms of the Creative Commons Attribution-NonCommercial License (CC BY-NC). Readers may copy, distribute, and display the work for non-commercial purposes with the proper citation of the original work. Electronic ISSN 1658-3175. Print ISSN 0379-5284.